Search

everythinglearnresearchcommunity

for

Search:↓

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Long COVID causes various long-term health issues and needs better awareness and treatment.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

Possible link between androgens and COVID-19 severity; more research needed.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

Women with PCOS are more vulnerable to severe COVID-19 and related health issues.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

The authors suggest that scalp hair might protect against COVID-19 and call for more research on scalp health and the virus.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

No significant link between male pattern baldness and COVID-19 severity was found.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Testosterone may influence COVID-19 severity and outcomes.

Some drugs may help treat both COVID-19 and radiation injury.

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.